Actiblok IPR 50 Tablet PR
Marketer
Biocon
Salt Composition
Metoprolol Succinate (47.5mg)
Overview Actiblok IPR 50 Tablet PR
Betapace PR 50mg tablets, a beta-blocker medication, effectively manages hypertension, angina pectoris, and cardiac arrhythmias. This medication also aids in migraine prophylaxis and reduces the risk of future myocardial infarctions and cerebrovascular accidents. Dosage and frequency are individualized, depending on the specific condition and its severity; it can be administered with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic benefits may not be apparent for several weeks, and continuous use may be necessary, even with symptom improvement, as discontinuation can exacerbate underlying conditions. Common, typically mild and transient, adverse reactions include fatigue, cephalgia, dysphoria, diarrhea, cutaneous eruptions, bradycardia, dizziness, and nausea. Less frequent side effects might encompass dyspnea or hypotension. Gradual dose escalation minimizes adverse event risk. Report any persistent or bothersome side effects to your physician. Prior to initiating treatment, disclose any hepatic impairment to your physician. This medication may be contraindicated in individuals with pre-existing bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating women require medical consultation before use. Individual suitability necessitates a physician's assessment. Regular blood pressure monitoring ensures treatment efficacy. Alcohol consumption should be avoided due to potential adverse effect amplification.
Primary Ingredients of Actiblok IPR 50 Tablet PR
No text provided. Please provide the text you wish me to rephrase.
Uses of Actiblok IPR 50 Tablet PR
Managing angina pectoris (chest discomfort linked to the heart)|Correcting cardiac arrhythmias|Averting myocardial infarction|Controlling hypertension (elevated blood pressure)|Preventing migraine headaches
Major Benefits of Actiblok IPR 50 Tablet PR:
Follow your doctor's instructions or consult the product label for usage guidance. Actiblok IPR 50 Tablet PR can be administered with or without food; however, consistent timing is recommended. For optimal absorption, it's advisable to avoid consuming Actiblok IPR 50 Tablet PR with meals high in fat, including olive oil, nuts and seeds (particularly Brazil nuts), dark chocolate, butter, and fatty meats.
Common Side effects of Actiblok IPR 50 Tablet PR:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Actiblok IPR 50 Tablet PR:
Follow your doctor's instructions or consult the product label for proper administration. Actiblok IPR 50 Tablet PR can be ingested with or without food; however, consistent timing is recommended. For optimal absorption, it's advisable to avoid consuming Actiblok IPR 50 Tablet PR concurrently with meals rich in fat, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and red meat.
How Actiblok IPR 50 Tablet PR works:
Cardiogard 50mg extended-release tablets are a selective beta-adrenergic antagonist, targeting cardiac function. They reduce heart rate and enhance the heart's pumping efficiency, improving systemic circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Actiblok IPR 50 Tablet PR with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Actiblok IPR 50 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Medical advice is recommended.
Breast feedingSAFE IF PRESCRIBED
The use of Actiblok IPR 50 Tablet PR while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Actiblok IPR 50 Tablet PR might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Actiblok IPR 50 Tablet PR presents no contraindications for use in patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Actiblok IPR 50 Tablet PR. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Actiblok IPR 50 Tablet PR :
Should you forget to take your Actiblok IPR 50 Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Actiblok IPR 50 Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | Heart |



